Dr. Yosep Ji is the Chief Executive Officer of HEM Pharma, a biotechnology company specializing in microbiome-based healthcare and therapeutics. He previously served as a Research Associate Professor at Handong Global University, Korea, where he led research on the human microbiome. His expertise includes probiotics, gut microbiota modulation, and health biomarker discovery and validation. He focuses on understanding microbial influences on host physiology and translating findings into clinical applications. Under his leadership, HEM Pharma develops live biotherapeutic products for metabolic and inflammatory diseases and expands personalized healthcare services through microbiome analysis, precision monitoring, and nutrition-based solutions.